New hope for lymphoma patients after CAR T-Cell failure
NCT ID NCT04703686
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a drug called glofitamab in 67 people with certain types of lymphoma (a blood cancer) that did not respond to or came back after CAR T-cell therapy. Participants received a pre-treatment followed by up to 11 cycles of glofitamab. The goal was to see if this antibody could shrink or control the cancer. The trial is now complete.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIFFUSE LARGE B-CELL LYMPHOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
APHP - Hôpital Saint Antoine
Paris, France
-
APHP - Hôpital de la Pitiè Salpetrière
Paris, France
-
CHRU Lille - Hôpital Claude Huriez
Lille, 59037, France
-
CHU Amiens Picardie Site sud
Amiens, France
-
CHU Lyon Sud
Pierre-Bénite, 69130, France
-
CHU Montpellier
Montpellier, 34295, France
-
CHU Nantes
Nantes, 44093, France
-
CHU Tours Hopital Bretonneau
Tours, 37044, France
-
CHU de Bordeaux - Hôpital Haut Leveque
Pessac, 33604, France
-
CHU de Brabois
Vandœuvre-lès-Nancy, France
-
CHU de Clermont Ferrand
Clermont-Ferrand, 63000, France
-
CHU de Dijon - Hôpital le Bocage
Dijon, 21034, France
-
CHU de Grenoble
Grenoble, 38043, France
-
CHU de Rennes - Hôpital Pontchaillou
Rennes, 35033, France
-
Centre Henri Becquerel
Rouen, 76038, France
-
Hopital Henri Mondor
Créteil, 94010, France
-
Hopital Necker enfants malades
Paris, 7574, France
-
Hôpital Saint Louis
Paris, 75475, France
-
IUCT Oncopole
Toulouse, 31059, France